/Investor DB

BioStar Ventures — Full Portfolio

12 tracked investments · listed companies and verified rows first

Autonomix Medicalautonomix.cominNASDAQ: AMIX

Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure.

Deep TechHealthtechMedical DevicesThe Woodlands, US

David Robins(Director)Robert Schwartz(Executive Officer)inLandy Toth(Chief Technology Officer)Matthew Lourie(Executive Officer)Robert Van Tassel(Executive Officer)Brad Hauser(Chief Executive Officer and President)in

Ablative Solutionsablativesolutions.com

HealthtechWakefield, US

Tim A. Fischell(Executive Officer, Director)inKate Rumrill(Executive Officer, Director)Lisa Mastromattei(Executive Officer)Ronald D Bache(Executive Officer, Director)Vartan E. Ghazarossian(Executive Officer, Director)David R. Fischell(Director)

Co-investorsMichigan Capital NetworkGilde HealthcareMAF

Aria CVariacv.comSeries A · Jul 2015 · $8M

BiotechHealthtechSt. Paul, US

Joshua Woolley(Executive Officer)inRyan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)inPeter DeLange(Executive Officer)inBruce A. Machmeier(Executive Officer)

Co-investorsAngel Physicians FundBrightstone Venture CapitalBroadview VenturesCatalyst Health VenturesPortfoliaXeraya Capital

Ellipseellipse.lain

Ellipse World develops payment card and smartcard technology aimed at reducing fraud and making digital payments safer for the financial industry and e-commerce.

CybersecurityFintechHardwareCulver City, US

Cyril Lalo(CEO & Founder)inSebastien Pochic(Chief Technology Officer)inGabrielle Levy(Chief Financial Officer)inMike Gaffney(President)inJacques Essebag(Director)

Co-investorsTrousdale VenturesUpfront Ventures

Foldaxfoldax.comin𝕏

Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.

Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US

Frank Maguire(Executive Officer, Director)

BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)

Co-investorsAngel Physicians FundKairos Venture Investments, LlcMemorialCare Innovation FundBioStar CapitalKairos Venture PartnersSUMMATION HEALTH VENTURES

Tricetrice.coin

Trice provides real-time payment processing through an embedded API that enables businesses to receive funds instantly without chargeback or reversal concerns.

Developer ToolsFintechSaaS

Doug Yeager(CEO)in

Co-investorsLightspeed Venture PartnersDiagramFINTOP CapitalGaingelsHealthQuest Capital

Trice Medicaltricemedical.comin

Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy.

BiotechHealthtechMedical DevicesMalvern, US

Jeffrey O'Donnell(Executive Officer, Director)Mark Foster(Executive Officer, Director)inRichard Kienzle(Executive Officer, Director)in

BoardAlan Davis(Director)Randy Scott(Director)inGary Kurtzman(Director)

Co-investorsHealthQuest Capital

VytronUSvytronus.comOct 2014 · $31.6M

HealthtechSunnyvale, US

John Pavlidis(Executive Officer, Director)Michael Horzewski(Executive Officer, Director)Michael Pederson(Executive Officer, Director)

BoardDavid McIntyre(Director)Justin Klein(Director)Sami Hamade(Director)

Co-investorsNew Enterprise Associates (NEA)Windham Capital Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Corindus Vascular RoboticsConventus OrthopaedicsEllipse TechnologiesKona Medical

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.